SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 741.45-1.1%Jan 30 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cl who wrote (24)1/6/1997 6:03:00 AM
From: Patrick Slevin   of 3560
 
I think it is a coincidence.

Amgen owns a large block of REGN, so in theory Amgen is worth more when REGN is trading higher. But relative to Amgen's size, I don't think Regeneron is enuf to move that stock.

An options analyst, McMillan, told his daily fax clients to buy the stock today, based on increased speculative buying in the calls. (He said to buy up to 18.5, I'm sure he used that number because of the resistance there. From there to about 19.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News